MedTrace Logo

Phase 1 Trial of Chlorogenic Acid in Patients With Advanced Cancer

NCT02136342 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2014-10-21

No results posted yet for this study

Summary

The purpose of the study is to explore if chlorogenic acid is safe in patients with cancer.

Conditions

Interventions

DRUG

chlorogenic acid

Sponsors & Collaborators

  • Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd

    collaborator INDUSTRY

  • Chinese Academy of Medical Sciences

    lead OTHER

Principal Investigators

  • Yuankai Shi, Dr. · Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2015-08-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02136342 on ClinicalTrials.gov